Skip to main content
SpringerLink
Log in

Sentinel Node Biopsy and Axillary Dissection

  • Chapter
Oncologic Breast Surgery

Part of the book series: Updates in Surgery ((UPDATESSURG))

  • 1768 Accesses

Abstract

The extent of axillary dissection has changed over time according to the evolution in understanding breast cancer characteristics. The first complete axillary lymph node dissection (ALND) was described in 1894 by Halsted in his reports on the technique for “radical mastectomy”; in the “Halsted hypothesis”, in which breast cancer was considered a local disease, ALND was intended to be curative [1].

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 109.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Hardcover Book
USD 179.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Halsted WS (1894) The results of operations for the cure of cancer of the breast performed at the Johns Hopkins Hospital from June 1889 to January 1894. Johns Hopkins Hosp Rep 4:297–350

    Google Scholar 

  2. Fisher B (1980) Laboratory and clinical research in breast cancer: a personal adventure. Cancer Res 40:3863–3874

    CAS  PubMed  Google Scholar 

  3. Krag DN, Weaver DL, Alex JC et al (1993) Surgical resection and radiolocalization of the sentinel lymph node in breast cancer using a gamma probe. Surg Oncol 2:335–340

    Article  CAS  PubMed  Google Scholar 

  4. Giuliano AE, Kirgan DM, Guenther JM et al (1994) Lymphatic mapping and sentinel lymphadenectomy for breast cancer. Ann Surg 220:391–401

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  5. Turner RR, Ollila DW, Krasne DL et al (1997) Histologic validation of the sentinel lymph node hypothesis for breast carcinoma. Ann Surg 226:271–278

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  6. Weaver DL, Krag DN, Ashikaga T et al (2000) Pathologic analysis of sentinel and non-sentinel lymph nodes in breast carcinoma: a multicenter study. Cancer 88:1099–1107

    Article  CAS  PubMed  Google Scholar 

  7. Walsh N, Kilk JV et al (2012) Ipsilateral nodal recurrence after axillary dissection for breast cancer. J Surg Res 177:81–86

    Article  PubMed  Google Scholar 

  8. Voogd AC, Kranelbrogh S et al (2005) Long-term prognosis of patients with axillary recurrence after axillary dissection for invasive breast cancer. Eur J Surg Oncol 31:485–489

    Article  CAS  PubMed  Google Scholar 

  9. Lythgoe JP, Palmer MK (1982) Manchester regional breast study-5 and 10 years results. Br J Surg 69:693–696

    Article  CAS  PubMed  Google Scholar 

  10. Newman LA, Hunt KK et al (2000) Presentation, management and outcome of axillary recurrence from breast cancer. Am J Surg 180:252–256

    Article  CAS  PubMed  Google Scholar 

  11. Shen SC, Liao CH et al (2012) Favorable outcome of secondary axillary dissection in breast cancer patients with axillary node relapse. Ann Surg Oncol 19:1122–1288

    Article  PubMed  Google Scholar 

  12. Shangani M, Balk EM et al (2009) Impact of axillary lymph node dissection on breast cancer outcome in clinically node negative patients: a sistematic review and meta-analysis. Cancer 115:1613–1620

    Article  Google Scholar 

  13. Wang Z, Wu LC, et al (2011) Sentinel lymph node biopsy compared with axillary lymph node dissection in early breast cancer: a meta-analysis. Breast Cancer Res Treat 129: 675–689

    Article  PubMed  Google Scholar 

  14. Early Breast Cancer Trialists’ Collaborative Group (2005) Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials. Lancet 365:1687–1717

    Article  Google Scholar 

  15. Goldhirsch A, Wood WC, Coates AS et al (2011) Strategies for subtypes-dealing with diversity of breast cancer: highlights of the St. Gallen International Expert Consensus of the Primary Therapy of Early breast cancer 2011. Ann Oncol 22:1736–1747

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  16. Cody HS, Fey J, Akhurst T et al(2001) Complementarity of blu dye and isotope in sentinelnode localization for breast cancer: univariate and multivariate analysis of 966 procedures. Ann Surg Oncol 8:13–19

    Article  PubMed  Google Scholar 

  17. Kim T, Giuliano AE, Lyman GH (2006) Lymphatic mapping and sentinel lymph node biopsy in early-stage breast carcinoma. Cancer 106:4–16

    Article  PubMed  Google Scholar 

  18. Pelosi E, Ala A, Bello’ M et al (2005) Impact of axillary nodal metastases on lymphatic mapping and sentinel lymph node identification rate in patient with early stage breast cancer. Eur J Nucl Med Mol Imaging 32:937–942

    Article  PubMed  Google Scholar 

  19. Martin RC, Edwards MJ, Wong et al (2001) Pratical guidelines for optimal gamma probe detection of sentinel lymph nodes in breast cance: results of a multi-institutional study. S urgery 128:139–144

    Google Scholar 

  20. Montgomery LL, Thorne AC, Van Zee KJ et al(2002) Isosulfan blu dye reactions durino sentinel lymph nodemapping for breast cancer. Anesth Analg 95:385–388

    PubMed  Google Scholar 

  21. Kitai T, Inomoto T, Shikayama T (2005) Fluorescence navigation with indocyanine green for detecting sentinel lymph nodes in breast cancer. Breast Cancer 12:211–215

    Article  PubMed  Google Scholar 

  22. Klimberg VS, Rubio IT, Henry R et al (1999) Subareolar versus peritumoral injection for location of the sentinel lymph node. Ann Surg 229:860–865

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  23. Roumen RMH, Geuskens LM, Valkenburg JCH (1999) In search of the true sentinel node by different injection techniques in breast cancer patients. Eur J Surg Oncol 25:347–351

    Article  CAS  PubMed  Google Scholar 

  24. Pelosi E, Bellò M, Giors M et al (2004) Sentinel limph node detection in patients with earlystage breast cancer: comparision of periareolar and subdermal/peritumoral injection techniques. J NucMed 45:220–225

    Google Scholar 

  25. Weaver DL, Ashikaga T, Krag DN et al (2011) Effect of occult metastases on survival in nodenegative breast cancer. New Engl J Med 364:412–421

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  26. Rutgers EJ (2008) Sentinel node biopsy: interpretation and management of patients with immunoistochemistry-positive sentinel node and those with micrometastases. J Clin Oncol 26:698–702

    Article  PubMed  Google Scholar 

  27. Houssami N, Ciatto S, Turner RM, Cody III HS, Macaskill P (2011) Preoperative ultrasoundguided needle biopsy of axillary nodes in invasive breast cancer: meta-analysis of its accuracy and utility in staging the axilla. Ann Surg 254:243–251

    Article  PubMed  Google Scholar 

  28. Kelly AM, Dwamena B, Cronin P et al (2009) Breast cancer sentinel node identification an classification after neoadjuvant chemotherapy: systematic rewiew and meta-analysis. Acad Radiol 16:551–563

    Article  PubMed  Google Scholar 

  29. Shen J, Gilcrease MZ, Babiera GV et al (2007) Feasibility and accuracy of sentinel lymph node biopsy after preoperative chemotherapy in breast cancer patients with documented axillary metastases. Cancer 109:1255–1263

    Article  PubMed  Google Scholar 

  30. Goyal A, Douglas-Jones A, Monypenny I et al (2006) Is there a role of sentinel lymph node biopsy in ductal carcinoma in situ?: analysis of 587 cases. Breast Cancer Res Treat 98:311–314

    Article  PubMed  Google Scholar 

  31. Laronga C, Lee MC, McGuire KP et al (2009) Indications for sentinel lymph node biopsy in the setting of prophylactic mastectomy. J Am Coll Surg 209:746–752

    Article  PubMed  Google Scholar 

  32. Nasser SM, Smith SG, Chapgar AB (2010) The role of sentinel node biopsy in women undergoing prophylactic mastectomy. J Surg Res 164:188–192

    Article  PubMed  Google Scholar 

  33. Krag DN, Anderson SJ, Julian TB et al (2010) Sentinel-lymph-node resection compared with conventional axillary — lymph-node dissection in clinically node-negative patients with breast cancer: overall survival findings from the NSABP B-32 randomized phase 3 trial. Lancet Oncol 11:927–933

    Article  PubMed Central  PubMed  Google Scholar 

  34. Reed J, Rosman M, Verbanac KM et al (2009) Prognostic implication of isolated tumor cells and micrometastases in sentinel nodes of patients with invasive breast cancer: 10 year analysis of patients enrolled in the prospective East Carolina University/Anne Arundel Medical Center sentinel node multicenter study. J Am Coll Surg 208:333–340

    Article  PubMed  Google Scholar 

  35. De Boer M, van Deurzen C, van Dijck J et al (2009) Micrometastases or isolate tumor cells and the outcome of breast cancer. N Engl J Med 361:653–663

    Article  PubMed  Google Scholar 

  36. Kahn HJ, Hanna WM, Chapman JA et al (2006) Biological significance of occult micrometastases in breast cancer patients using the recent American Joint Committee on Cancer breast cancer staging system. Breast 12:294–301

    Article  Google Scholar 

  37. Godardhan PD, Elias SG, Madsen EVE et al (2009) Prognostic value of micrometastases in sentinel lymph node of patients with breast carcinoma: a cohort study. Ann Oncol 20:41–48

    Article  Google Scholar 

  38. Galimberti V, Botteri E, Chifu C et al (2012) Can we avoid axillary dissection in the micrometastatic sentinel node in breast cancer? Breast Cancer Rest Treat 131:819–825

    Article  Google Scholar 

  39. Toussaint A, Nogaret JM, Hertens D et al (2011) Axillary rate recurrence in breast cancer patients with negative sentinel lymph node biopsy or containing micrometastases and without further lymphoadenectomy: a monocentric rewiev o 8 years and 481 cases. Breast J 17:337–342

    Article  PubMed  Google Scholar 

  40. Pernas S, Gil M, Benitez A et al (2010) Avoiding axillary treatment in sentinel lymph node micrometastases of breast cancer: a prospective analysis of axillary or distant recurrence. Ann Sur Oncol 17:772–777

    Article  Google Scholar 

  41. Bilimoria KY, Bentrem DJ, Hansen NM et al (2009) Comparison of sentinel lymph node biopsy alone and complete axillary lymph node dissection for node-positive breast cancer. J Clin Oncol 27:2946–2953

    Article  PubMed  Google Scholar 

  42. Pepels MJ, de Boer M, Bult P, van Dijck Ja et al (2012) Regional recurrence in breast cancer patients with sentinel micrometastases and isolated tumor cells. Ann Surg 255:116–121

    Article  PubMed  Google Scholar 

  43. Giuliano AE, McCall L, Beitsch P et al (2010) Locoregional recurrence after sentinel lymph node dissection with or without axillary dissection in patients with sentinel lymph node metastases: the American College of Surgeons Oncology Group Z0011 randomized trial. Ann Surg 252:426–433

    PubMed  Google Scholar 

  44. Giuliano AE, Hunt KK, Ballman KV et al (2011) Axillary dissection vs. no axillary dissection in women with invasive breast cancer and sentinel node metastasis: a randomized clinical trial. JAMA 305:560–575

    Google Scholar 

  45. Straver ME, Meijenen P, van Tienhoven G et al (2012)Role of axillary clearance after a tumor-positive sentinel node in the administration of adjuvant therapy in early breast cancer. J Clin Oncol 28:731–732

    Article  Google Scholar 

  46. Liu CQ, Guo Y, Shi JY et al (2009) Late morbidity associated with a tumor-negative sentinel lymph node biopsy in primary breast cancer patient: a systematic review. Eur J Cancer 45:1560–1568

    Article  PubMed  Google Scholar 

  47. Dabakuyo TS, Fraisse J, Causeret S et al (2009) A multicenter cohort study to compare quality of life in breast cancer patients according to sentinel lymph node biopsy or axillary lymph node dissection. Ann Oncol 20:1352–1361

    Article  CAS  PubMed  Google Scholar 

  48. Fleissig A, Fallowfield LJ, Langridge CI et al (2006) Post-operative arm morbidity and quality of life. Result of the ALMANAC randomised trial comparing sentinel node biopsy with standard axillary treatment in the management of patient with early breast cancer. Breast Cancer Res Treat 95:279–293

    Article  PubMed  Google Scholar 

  49. Chen JJ, Huang XY, Liu ZB et al (2009) Sentinel node biopsy and quality of life measures in a Chinese population. Eur J Surg Oncol 35:921–927

    Article  PubMed  Google Scholar 

  50. Kell MR, Burke JP, Barry M et al (2010) Outcome of axillary staging in early breast cancer: a meta-analysis. Breast Cancer Res Treat 120:441–447

    Article  PubMed  Google Scholar 

  51. Rietman JS, Dijkstra PU, Geertzen JH et al (2004) Treatment-related upper limb morbidity 1 year after sentinel lymph node biopsy or axillary lymph node dissection for stage I or II breast cancer. Ann Surg Oncol 11:1018–1024

    Article  CAS  PubMed  Google Scholar 

  52. Erickson VS, Pearson ML, Ganz PA et al (2001) Arm edema in breast cancer patient. J Natl Cancer Inst 93:96–111

    Article  CAS  PubMed  Google Scholar 

  53. Koostra J, Hoekstra Weebers JE, Rietmann H et al (2008) Quality of life after sentinel lymph node biopsy or axillary lymph node dissection in stage I II breast cancer patients: a prospective longitudinal study. A Surg Oncol 15:2533–2541

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Surgery, Breast Surgery Unit, Città della Salute e della Scienza Hospital, Turin, Italy

    Ada Ala

Authors
  1. Riccardo Bussone
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Ada Ala
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Pietro Maria Ferrando
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Gretha Grilz
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Ada Ala .

Editor information

Editors and Affiliations

  1. Department of Surgery Breast Surgery Unit, Ospedali Riuniti University Hospital, Ancona, Italy

    Carlo Mariotti

Rights and permissions

Reprints and permissions

Copyright information

© 2014 Springer-Verlag Italia

About this chapter

Cite this chapter

Bussone, R., Ala, A., Ferrando, P.M., Grilz, G. (2014). Sentinel Node Biopsy and Axillary Dissection. In: Mariotti, C. (eds) Oncologic Breast Surgery. Updates in Surgery. Springer, Milano. https://doi.org/10.1007/978-88-470-5438-7_6

Download citation

  • DOI: https://doi.org/10.1007/978-88-470-5438-7_6

  • Publisher Name: Springer, Milano

  • Print ISBN: 978-88-470-5437-0

  • Online ISBN: 978-88-470-5438-7

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation